Lunit Inc 2024 SR
The report highlights Lunit's 2024 performance, focusing on its mission to conquer cancer through AI. Key milestones include the acquisition of Volpara Health and a strategic partnership with AstraZeneca to develop AI-powered pathology solutions. The company established a Sustainability Management Council and committed to achieving Net Zero emissions by 2040. Lunit also officially joined the UN Global Compact and initiated the process for SBTi commitment. The report details progress in healthcare accessibility, data security, and talent development while adhering to GRI and SASB standards.
Company: Lunit Inc
Sector: Media & publishing
Country: South Korea
Year: 2024
Type: SR
Pages: 66
Lunit Inc
The report highlights Lunit's 2024 performance, focusing on its mission to conquer cancer through AI. Key milestones include the acquisition of Volpara Health and a strategic partnership with AstraZeneca to develop AI-powered pathology solutions. The company established a Sustainability Management Council and committed to achieving Net Zero emissions by 2040. Lunit also officially joined the UN Global Compact and initiated the process for SBTi commitment. The report details progress in healthcare accessibility, data security, and talent development while adhering to GRI and SASB standards.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees